22ND MEET THE PROFESSOR. ADVANCED INTERNATIONAL BREAST CANCER COURSE (AIBCC)

• PIERFRANCO CONTE· MEDICO PROFESSORE ORDINARIO ONCOLOGIA
• VALENTINA GUARNERI· MEDICO PROFESSORE ORDINARIO DIRETTORE ONCOLOGIA
• PHILIP POORTMANS· HEAD DEPT RADIATION ONCOLOGY-MARIE CURIE

• BANU ARUN· RELATORE
• BETTINA BORISCH· RELATORE
• MICHELE BOTTOSSO· RELATORE
• PIERFRANCO CONTE· RELATORE
• GIUSEPPE CURIGLIANO· MODERATORE
• CARMINE DE ANGELIS· RELATORE
• MICHELINO DE LAURENTIIS· MODERATORE
• LUCIA DEL MASTRO· MODERATORE
• MARIA VITTORIA DIECI· RELATORE
• HESHAM AHMED GABALLAH ELGHAZALY· RELATORE
• PETER FASCHING· RELATORE
• MARIO GIULIANO· RELATORE
• GAIA GRIGUOLO· RELATORE
• VALENTINA GUARNERI· RELATORE
• JACEK JASSEM· RELATORE
• STEPHEN JOHNSTON· RELATORE
• MATTEO LAMBERTINI· RELATORE
• SIBYLLE LOIBL· RELATORE
• LUCA MALORNI· RELATORE
• ELEFTHERIOS MAMOUNAS· RELATORE
• DAVIDE MASSA· RELATORE
• FEDERICA MIGLIETTA· RELATORE
• FEDRO ALESSANDRO PECCATORI· RELATORE
• FREDERIQUE PENAULT-LLORCA· RELATORE
• PHILIP POORTMANS· RELATORE
• ALEIX PRAT· RELATORE
• FABIO PUGLISI· MODERATORE
• HOPE RUGO· RELATORE
• GRAZIA SCOCCA· RELATORE
• TANJA SPANIC· RELATORE
• SANDRA SWAIN M· RELATORE

Ragione sociale

ACCADEMIA NAZIONALE DI MEDICINA

Stato accreditamento

STANDARD - 2° rinnovo

Professionali

Breast cancer research has been the frontrunner in many fields of cancer research and thanks to this knowledge, today many breast cancers can be prevented, most can be diagnosed at early stages and cured and the minority of patients at advanced stages can still enjoy a significant survival with a reasonable quality of life. New prognostic and predictive biomarkers are available, need to be validated and to be implemented in trial design and clinical practice. Risk-adapted surgery and radiation therapy allow for less and less invasive procedures. Multiple effective adjuvant therapies in the different molecular breast cancer subtypes, require a more precise definition of risk and predictivity of drug efficacy, to allow for a rational de-escalation or escalation of curative treatments.the 22nd aibcc in padova, will allow to sum up the most recent biological and clinical achievements and to allow an open and friendly discussion of clinical cases among key opinion leaders and participants

#18Contenuti tecnico-professionali (conoscenze e competenze) specifici di ciascuna professione, di ciascuna specializzazione e di ciascuna attività ultraspecialistica, ivi incluse le malattie rare e la medicina di genere

Area: Obiettivi formativi tecnico-professionali

Partecipanti max

100

Verifica presenza

Sistema Elettronico A Badges

Verifica apprendimento

Questionario A Risposta Multipla Online